Cutler Group’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-846
Closed -$17K 7253
2017
Q1
$17K Sell
846
-133
-14% -$2.56K ﹤0.01% 3519
2016
Q4
$15K Sell
979
-173
-15% -$3.17K ﹤0.01% 3788
2016
Q3
$25K Buy
1,152
+173
+18% +$3.98K ﹤0.01% 3206
2016
Q2
$18K Hold
979
﹤0.01% 3500
2016
Q1
$25K Sell
979
-94
-9% -$2.93K ﹤0.01% 3066
2015
Q4
$38K Buy
+1,073
New +$46.6K ﹤0.01% 2769

Other funds holding ALIM

Cutler Group's ALIM Position: Q2 2017 in Review

Cutler Group sold out of Alimera Sciences (ALIM) in Q2 2017, closing a stake of 846 shares — an estimated $17K sold.

Cutler Group first reported a position in ALIM in Q4 2015 and held it in 6 quarters. The position peaked at $38K in Q4 2015. 38 funds tracked by Wall St. Rank hold ALIM as of Q2 2017.

  • Cutler Group reported no remaining Alimera Sciences position as of Q2 2017 after selling out during the quarter.
  • Cutler Group sold 846 Alimera Sciences shares in Q2 2017, an estimated $17K.
  • Cutler Group first reported a position in Alimera Sciences in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Alimera Sciences position peaked at $38K in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.